Beryl Drugs Ltd.

Financial

	Beryl Drugs	Colinz Laboratories	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	2.54 %	4.05 %	-1624.87 %
5yr average Equity Multiplier	2.23	1.3	46.04
5yr Average Asset Turnover Ratio	1.08	0.7	0.95
5yr Avg Net Profit Margin	0.66 %	4.66 %	-9.48 %
Price to Book	1.26	1.16	0.0
P/E	52.2	22.36	0.0
5yr Avg Cash Conversion Cycle	-619.24 Days	-0.66 Days	-161.05 Days
Inventory Days	36.1 Days	64.79 Days	73.65 Days
Days Receivable	98.89 Days	51.75 Days	40.27 Days
Days Payable	969.29 Days	78.66 Days	328.05 Days
5yr Average Interest Coverage Ratio	1.68	9.16	1.16
5yr Avg ROCE	5.73 %	6.01 %	-9.94 %
5yr Avg Operating Profit Margin	7.19 %	6.82 %	3.93 %
5 yr average Debt to Equity	0.64	0.07	17.42
5yr CAGR Net Profit	72.78 %	30.39 %	n/a
5yr Average Return on Assets	1.31 %	3.14 %	-6.43 %
Shareholdings
Promoter Holding	26.38 %	66.0 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.46 %	-0.01 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0